- Home
- ALLO vs SFST Comparison
ALLO vs SFST Comparison
Compare ALLO & SFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ALLO | SFST |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 578.6M |
| IPO Year | 2018 | 2012 |
Fundamental Metrics
Financial Performance| Metric | ALLO | SFST |
|---|---|---|
| Price | $1.85 | $61.01 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 15 | 1 |
| Target Price | $8.35 | ★ $64.00 |
| AVG Volume (30 Days) | ★ 10.6M | 137.5K |
| Earning Date | 05-07-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 34.09 | ★ 94.76 |
| EPS | N/A | ★ 1.19 |
| Revenue | N/A | ★ $6,282,000.00 |
| Revenue This Year | N/A | $10.47 |
| Revenue Next Year | $142,416.42 | $12.19 |
| P/E Ratio | ★ N/A | $51.59 |
| Revenue Growth | N/A | ★ 12.99 |
| 52 Week Low | $0.99 | $39.60 |
| 52 Week High | $4.46 | $64.06 |
Technical Indicators
Market Signals| Indicator | ALLO | SFST |
|---|---|---|
| Relative Strength Index (RSI) | 40.97 | 51.77 |
| Support Level | $1.56 | $59.26 |
| Resistance Level | $1.92 | $61.81 |
| Average True Range (ATR) | 0.12 | 1.89 |
| MACD | -0.03 | -0.08 |
| Stochastic Oscillator | 22.47 | 49.42 |
Price Performance
Historical ComparisonAbout ALLO Allogene Therapeutics Inc.
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf" T cell candidates designed to target cancer cells or eliminate autoreactive cells in patients with autoimmune disorders. Its three core programs are: Large B-Cell Lymphoma (LBCL), Autoimmune Disease (AID) and Renal Cell Carcinoma (RCC).
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. Through its banking subsidiary, it is engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer, and mortgage loans, ATM processing, and other banking products and services to the general public. The group operates through various retail offices located in the Greenville, Columbia, and Charleston markets of South Carolina, three retail offices in the Raleigh, Greensboro, and Charlotte markets of North Carolina, and one retail office in Atlanta, Georgia.